Solid Form Screening Services
Our experienced solid form experts provide the pharmaceutical industry with solid form services including salt screening, co-crystal screening, crystallisation screening, polymorph screening.
Critical effective solid form screening
Understanding the solid form options early in the development of an investigative pharmaceutical candidate is critical for efficient progress towards clinical success and ensuring robust and consistent production of the most optimised version for in-vitro assessment.
The experienced team are experts in the design and completion of efficient solid form screens. Our comprehensive Materials Science capabilities allow us to offer a Solid Form Screening and Selection service for viable crystalline versions including salts, cocrystals and polymorphs.
Our Solid Form Screening Services
Our solid form work programmes include:
- Bespoke salt screening by experienced specialists designed to meet your objectives
- Polymorph screening
- Cocrystal screen design and discovery
- Scale up and comprehensive analysis of selected forms
- Interpretation and recommendation
Speed up your small molecule drug development programme
Our Solid Form services can support throughout the drug development process, from candidate selection and efficient processing through to ‘fit for purpose’ formulation and toxicity studies scale up, API and formulated drug substance manufacture.
We have developed a chemistry led approach which maximises hit rate of lead compounds whilst minimising compound requirement.
How it works
- An initial kick-off discussion to establish and understand your specific needs and objectives
- Using a chemistry-led approach we will design bespoke screening protocols with the aim of maximising hit rate while minimising compound requirement
- Selected forms would be scaled-up, fully characterised and compared to ensure the smoothest path into the next stage of development
Solid Form Screening Services
Salt Screening and Selection in Drug Discovery and Development.
Where a candidate molecule has one or more ionisable centres, salt screening can be a key step in drug development. Dramatic improvements in solubility and bioavailability in biological media have been achieved without the need for more complicated formulation options. Drug Development Solutions can perform one or more salt screens to accomplish this in conjunction with other desirable properties for an Active Pharmaceutical Ingredient (API) or Investigational Medicinal Product (IMP) such as solubility, stability and handleability.
Polymorph Screening Services in Pharmaceutical Compounds
It is a regulatory requirement that the polymorphic landscape of any approved pharmaceutical be well understood and controlled.
It is therefore important that the most stable and optimised form is identified and produced early in Pharmaceutical Development. This reduces the risk that unexpected adverse events, such as batch to batch variability, instability, processing issues and increased hygroscopicity, may occur later.
Drug Development Solutions can perform screens to investigate and understand the solid-state polymorphism associated with your compound. Using a variety of techniques, we aim to identify and characterize all major polymorphic forms as well as any hydrates and the potential for solvation of your API.
Cocrystal Screening and Selection
At Drug Development Solutions we are experts in cocrystal screening.
We provide cocrystal screens for sponsors where the molecule has no ionisable centre or suitable salt forms have not been found and where structural analysis indicates this may be a worthwhile route to explore.
Often when an API enters into development the solid form is not crystalline. We offer an extensive crystallisation service to assist you with your crystallisation and screening and deliver a scalable solution.
Solid Form Services -
Characterisation techniques offered
- Powder X-ray diffraction for crystallinity and polymorph identification
- Thermogravimetric analysis for hydrates and solvate identification
- Differential scanning calorimetry for purity and melting point
- Optical, Scanning Electron Microscopy and thermal microscopy
- Dynamic vapour sorption for hygroscopicity and effect of humidity
- NMR for chemical integrity
- Particle sizing
- High Performance Liquid chromatography if requested for solubility in water and biorelevant media
Your Trusted Partner for Solid Form Screening Services
Our team has extensive experience in synthetic and medicinal chemistry.
Why chemistry-led design brings the greatest value to pharmaceutical development
All candidates for development as pharmaceuticals will require screening to identify which solid forms are available whether free compound, salt, cocrystal, hydrate, or a polymorph of these.
Editorial by Kim James, Solid Form Expert, Drug Development Solutions
Download fact sheet
Download our Solid Form Screening and Selection factsheet to learn more about our solid form screening services
Solid Form Screening and Selection Centre of Excellence
Our Solid Form Screening and Selection Centre of Excellence builds on our expertise in Materials Science to offer the discovery and /or optimisation of crystalline forms of small molecule development candidates.
The centre is supported by expert and experienced materials science analysis using a wide range of analytical techniques operating to the highest quality standards.